Mehdi Zoghi Selected Research

Pathologic Constriction (Stenosis)

2/2018	The Severity of Coronary Arterial Stenosis in Patients With Acute ST-Elevated Myocardial Infarction: A Thrombolytic Therapy Study.
2/2008	High-sensitivity C-reactive protein may be an indicator of the development of atherosclerosis in myocardial bridging.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mehdi Zoghi Research Topics

Disease

14	Heart Failure 01/2021 - 12/2005
5	Atrial Fibrillation 01/2019 - 11/2011
5	Hypertension (High Blood Pressure) 07/2015 - 07/2003
4	ST Elevation Myocardial Infarction 01/2019 - 03/2007
3	Coronary Artery Disease (Coronary Atherosclerosis) 09/2020 - 09/2004
3	Hemorrhage 01/2019 - 08/2017
3	Infarction (Infarctions) 01/2019 - 03/2007
3	Thrombosis (Thrombus) 09/2016 - 01/2002
2	Cardiac Arrhythmias (Arrythmia) 04/2021 - 11/2011
2	Coronary Disease (Coronary Heart Disease) 01/2019 - 08/2012
2	Pathologic Constriction (Stenosis) 02/2018 - 02/2008
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2018 - 12/2005
2	Acute Coronary Syndrome 01/2013 - 12/2005
2	Insulin Resistance 11/2012 - 01/2006
2	Ischemia 04/2009 - 06/2007
2	Myocardial Bridging 02/2008 - 06/2007
1	Diabetes Mellitus 09/2020
1	Vitamin D Deficiency 11/2019
1	Cardiomyopathies (Cardiomyopathy) 08/2019
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2019
1	Chronic Renal Insufficiency 01/2019
1	Dementia (Dementias) 04/2018
1	Systolic Heart Failure 09/2016
1	Fistula 07/2015
1	Brugada Syndrome 03/2013
1	Arteritis 01/2013
1	Unstable Angina 01/2013
1	Vascular Diseases (Vascular Disease) 11/2012
1	Overweight 11/2012
1	Inflammation (Inflammations) 11/2012
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2012
1	Neoplasms (Cancer) 06/2011
1	Infections 03/2011
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 03/2011
1	Osteoporosis 05/2010
1	Myocardial Ischemia (Ischemic Heart Diseases) 04/2009
1	Hypocalcemia 01/2009
1	Vasovagal Syncope 12/2008
1	Metabolic Bone Diseases (Osteopenia) 03/2008
1	Atherosclerosis 02/2008
1	Hematologic Neoplasms (Hematological Malignancy) 06/2006
1	Hyperlipidemias (Hyperlipidemia) 01/2006
1	Erectile Dysfunction 01/2005
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 12/2004
1	Stable Angina 09/2004
1	Inferior Wall Myocardial Infarction 01/2003

Drug/Important Bio-Agent (IBA)

4	DiureticsIBA 07/2015 - 12/2004
3	Warfarin (Coumadin)FDA LinkGeneric 01/2019 - 08/2016
3	C-Reactive ProteinIBA 01/2013 - 09/2004
3	Simendan (Levosimendan)IBA 04/2009 - 01/2008
3	Dobutamine FDA LinkGeneric 04/2009 - 06/2007
3	CalciumIBA 01/2009 - 07/2003
2	Vitamin D FDA LinkGeneric 11/2019 - 01/2009
2	AnticoagulantsIBA 05/2018 - 04/2018
2	N(4)-oleylcytosine arabinosideIBA 05/2018 - 04/2018
2	Vitamin K FDA Link 05/2018 - 04/2018
2	EnzymesIBA 09/2016 - 01/2013
2	Pharmaceutical PreparationsIBA 03/2013 - 07/2003
2	ResistinIBA 08/2012 - 11/2011
2	Antihypertensive Agents (Antihypertensives)IBA 01/2005 - 12/2004
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2021
1	Neprilysin (Neutral Endopeptidase)IBA 01/2021
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 09/2020
1	pro-brain natriuretic peptide (1-76)IBA 08/2019
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2019
1	Cardiovascular AgentsIBA 01/2018
1	Heparin (Liquaemin)FDA LinkGeneric 09/2016
1	SolutionsIBA 09/2016
1	Glycoproteins (Glycoprotein)IBA 09/2016
1	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 09/2016
1	beta Adrenergic ReceptorsIBA 09/2016
1	CreatinineIBA 07/2015
1	Propafenone (Rythmol)FDA LinkGeneric 03/2013
1	chitotriosidaseIBA 01/2013
1	MB Form Creatine KinaseIBA 01/2013
1	Troponin T (Troponin T1)IBA 01/2013
1	LipidsIBA 11/2012
1	HomocysteineIBA 11/2012
1	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 11/2012
1	Angiotensin Receptor AntagonistsIBA 06/2011
1	Vasodilator Agents (Vasodilators)IBA 12/2009
1	Biological FactorsIBA 12/2008
1	Indicators and Reagents (Reagents)IBA 02/2008
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 03/2007
1	Atorvastatin (Lipitor)FDA Link 01/2006
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2006
1	Brain Natriuretic Peptide (Natrecor)FDA Link 12/2005
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 12/2004
1	candesartanIBA 07/2003
1	Felodipine (Agon)FDA LinkGeneric 07/2003

Therapy/Procedure

10	Therapeutics 04/2021 - 07/2003
6	Heart Transplantation (Grafting, Heart) 07/2015 - 01/2008
3	Thrombolytic Therapy 01/2019 - 01/2003
1	Percutaneous Coronary Intervention 01/2019
1	Secondary Prevention 01/2019
1	Heart-Assist Devices 09/2016
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 11/2011
1	Aftercare (After-Treatment) 01/2009
1	Transplantation 06/2006
1	Drug Therapy (Chemotherapy) 06/2006